Duragesic | Vibepedia

1. 🏥 Origins & History
2. 💡 How It Works
3. 🚨 Controversy & Criticism
4. 👥 Impact on Public Health
5. Frequently Asked Questions
6. Related Topics

Duragesic was first approved by the FDA in 1990, and it was initially marketed as a treatment for cancer pain. However, its use soon expanded to include other types of chronic pain, such as back pain and neuropathic pain. As the opioid crisis worsened, companies like Janssen Pharmaceuticals and Purdue Pharma faced increased scrutiny for their marketing practices, with critics arguing that they downplayed the risks of addiction and overdose. Experts like Dr. Andrew Kolodny, the co-founder of Physicians for Responsible Opioid Prescribing, have spoken out against the overprescription of opioids, citing the need for more stringent regulations and education for healthcare providers. Meanwhile, organizations like the CDC and the WHO have issued guidelines for the safe use of opioids, emphasizing the importance of alternative treatments and careful patient monitoring.

The Duragesic patch works by releasing a steady dose of fentanyl into the bloodstream through the skin. This provides long-lasting pain relief, typically for 48 to 72 hours. However, the patch can be abused by cutting it open and extracting the fentanyl, which can be ingested or injected. This has led to a black market for Duragesic patches, with some individuals selling them online or on the street. Law enforcement agencies, such as the DEA, have cracked down on these operations, but the problem persists. Researchers at institutions like the University of California, Los Angeles (UCLA) and the University of Michigan have studied the effects of fentanyl and other opioids on the brain, highlighting the need for more effective treatments for addiction and overdose.

The controversy surrounding Duragesic has led to numerous lawsuits and settlements. In 2015, Janssen Pharmaceuticals agreed to pay $2.04 billion to settle allegations that it had improperly marketed Duragesic and other opioid medications. Other companies, such as Purdue Pharma, have also faced lawsuits and criticism for their role in the opioid crisis. The crisis has been exacerbated by the overprescription of medications like Duragesic, as well as the lack of education and resources for healthcare providers. Experts like Dr. Sanjay Gupta, a neurosurgeon and CNN chief medical correspondent, have called for more stringent regulations and education for healthcare providers, emphasizing the need for alternative treatments and careful patient monitoring. Organizations like the American Medical Association (AMA) and the American Academy of Pain Medicine (AAPM) have also issued guidelines for the safe use of opioids, highlighting the importance of responsible prescribing practices.

The impact of Duragesic on public health has been significant. According to the CDC, more than 400,000 people have died from opioid overdoses in the United States since 1999. The opioid crisis has also led to increased rates of addiction, with many individuals becoming dependent on medications like Duragesic. To address this crisis, healthcare providers and policymakers are exploring alternative treatments, such as non-opioid pain medications and behavioral therapies. Companies like Google and Apple are also developing new technologies to help combat the opioid crisis, such as apps that provide education and support for individuals struggling with addiction. Researchers at institutions like Harvard University and the University of Oxford are studying the effects of opioids on the brain, highlighting the need for more effective treatments for addiction and overdose.

Year

1990

Origin

United States

Category

science

Type

product